Company Info
Phone(603) 759-6631
Year Established
2021
Contacts
Travis H. Brown, M.B.A.CEO
Mike Hager, CPA
CFO
Company Description
Aplexis is an early-stage therapeutic company focused on treating myeloproliferative neoplasms with characteristic Plek2 overexpression.